RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 154 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $85,236 | +3.5% | 78,922 | +23.7% | 0.00% | – |
| Q2 2023 | $82,329 | -45.0% | 63,821 | -43.7% | 0.00% | – |
| Q1 2023 | $149,582 | +30.8% | 113,320 | +48.6% | 0.00% | – |
| Q4 2022 | $114,368 | +28.5% | 76,245 | +1.5% | 0.00% | – |
| Q3 2022 | $89,000 | -9.2% | 75,090 | -13.3% | 0.00% | – |
| Q2 2022 | $98,000 | -66.7% | 86,619 | -11.9% | 0.00% | – |
| Q1 2022 | $294,000 | -1.0% | 98,333 | -12.2% | 0.00% | – |
| Q4 2021 | $297,000 | -23.3% | 111,951 | +5.2% | 0.00% | – |
| Q3 2021 | $387,000 | -18.7% | 106,464 | -2.9% | 0.00% | – |
| Q2 2021 | $476,000 | +19.0% | 109,629 | -6.3% | 0.00% | – |
| Q1 2021 | $400,000 | -10.3% | 117,058 | -8.1% | 0.00% | – |
| Q4 2020 | $446,000 | +49.2% | 127,405 | +2.3% | 0.00% | – |
| Q3 2020 | $299,000 | +89.2% | 124,524 | +44.1% | 0.00% | – |
| Q2 2020 | $158,000 | +75.6% | 86,411 | +51.1% | 0.00% | – |
| Q1 2020 | $90,000 | -92.7% | 57,201 | -90.0% | 0.00% | -100.0% |
| Q4 2019 | $1,228,000 | +27.5% | 574,569 | +11.3% | 0.00% | 0.0% |
| Q3 2019 | $963,000 | -68.2% | 516,083 | -55.5% | 0.00% | -50.0% |
| Q2 2019 | $3,026,000 | -39.9% | 1,159,854 | -40.8% | 0.00% | -33.3% |
| Q1 2019 | $5,032,000 | +40.2% | 1,959,172 | +25.5% | 0.00% | 0.0% |
| Q4 2018 | $3,589,000 | -62.0% | 1,561,163 | -47.0% | 0.00% | 0.0% |
| Q3 2018 | $9,457,000 | +5.1% | 2,946,793 | -7.3% | 0.00% | 0.0% |
| Q2 2018 | $8,999,000 | +94.7% | 3,180,392 | +143.4% | 0.00% | +50.0% |
| Q1 2018 | $4,623,000 | +10.6% | 1,306,389 | +21.2% | 0.00% | -33.3% |
| Q4 2017 | $4,180,000 | +463.3% | 1,077,663 | +268.0% | 0.00% | +200.0% |
| Q3 2017 | $742,000 | -41.5% | 292,816 | -37.1% | 0.00% | 0.0% |
| Q2 2017 | $1,269,000 | -19.0% | 465,711 | -1.8% | 0.00% | 0.0% |
| Q1 2017 | $1,567,000 | +10.4% | 474,253 | -20.5% | 0.00% | 0.0% |
| Q4 2016 | $1,419,000 | +48.9% | 596,578 | +129.4% | 0.00% | 0.0% |
| Q3 2016 | $953,000 | +566.4% | 260,061 | +302.5% | 0.00% | – |
| Q2 2016 | $143,000 | +31.2% | 64,604 | +22.0% | 0.00% | – |
| Q1 2016 | $109,000 | -42.0% | 52,959 | -15.3% | 0.00% | – |
| Q4 2015 | $188,000 | +16.0% | 62,491 | -5.7% | 0.00% | – |
| Q3 2015 | $162,000 | -19.4% | 66,237 | +4.5% | 0.00% | – |
| Q2 2015 | $201,000 | -71.6% | 63,406 | -68.1% | 0.00% | – |
| Q1 2015 | $708,000 | +50.6% | 198,469 | -4.5% | 0.00% | – |
| Q4 2014 | $470,000 | -13.9% | 207,844 | -26.4% | 0.00% | – |
| Q3 2014 | $546,000 | -63.5% | 282,490 | -31.5% | 0.00% | -100.0% |
| Q2 2014 | $1,494,000 | -4.9% | 412,106 | +1.7% | 0.00% | 0.0% |
| Q1 2014 | $1,571,000 | +8.8% | 405,397 | -20.1% | 0.00% | 0.0% |
| Q4 2013 | $1,444,000 | -37.4% | 507,649 | -21.2% | 0.00% | -50.0% |
| Q3 2013 | $2,305,000 | – | 644,429 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 9,105,691 | $30,140,000 | 5.99% |
| Sio Capital Management, LLC | 1,888,181 | $6,250,000 | 3.50% |
| DAFNA Capital Management LLC | 473,478 | $1,567,000 | 1.32% |
| Cormorant Asset Management, LP | 2,000,000 | $6,620,000 | 0.96% |
| Ghost Tree Capital, LLC | 1,100,000 | $3,641,000 | 0.68% |
| Rhenman & Partners Asset Management AB | 1,282,000 | $4,243,000 | 0.67% |
| Palo Alto Investors LP | 4,254,623 | $14,083,000 | 0.67% |
| NEA Management Company, LLC | 3,243,150 | $10,375,000 | 0.36% |
| Telemetry Investments, L.L.C. | 170,000 | $563,000 | 0.25% |
| NJ State Employees Deferred Compensation Plan | 355,000 | $1,175,000 | 0.22% |